| For: |
Zheng LD, Jiang GS, Pu JR, Mei H, Dong JH, Hou XH, Tong QS. Stable knockdown of heparanase expression in gastric cancer cells |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i43/5442.htm |
| Number | Citing Articles |
| 1 |
Esther Hermano, Immanuel Lerner, Michael Elkin. Heparanase enzyme in chronic inflammatory bowel disease and colon cancer. Cellular and Molecular Life Sciences 2012; 69(15) doi: 10.1007/s00018-012-0930-8
|
| 2 |
Adi Binder Gallimidi, Stuart Fischman, Brurya Revach, Raanan Bulvik, Alina Maliutina, Ariel M. Rubinstein, Gabriel Nussbaum, Michael Elkin. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget 2015; 6(26) doi: 10.18632/oncotarget.4209
|
| 3 |
Carolin Mogler, Christel Herold-Mende, Gerhard Dyckhoff, Ekkehart Jenetzky, Philipp Beckhove, Burkhard M Helmke. Heparanase expression in head and neck squamous cell carcinomas is associated with reduced proliferation and improved survival. Histopathology 2011; 58(6) doi: 10.1111/j.1365-2559.2011.03834.x
|
| 4 |
Xiao-Peng Chen, Jun-Sheng Luo, Ye Tian, Chen-Lin Nie, Wei Cui, Wei-Dong Zhang. Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells. BioMed Research International 2015; 2015 doi: 10.1155/2015/241983
|
| 5 |
CHAO CHENG, XIAOMING LU, GUOBIN WANG, LIDUAN ZHENG, XIAOGANG SHU, SHIKAI ZHU, KE LIU, KE WU, QIANG TONG. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS 2010; 118(11) doi: 10.1111/j.1600-0463.2010.02673.x
|
| 6 |
Hai-Long Li, Jing Gu, Jian-Jun Wu, Chun-Lin Ma, Ya-Li Yang, Hu-Ping Wang, Jing Wang, Yong Wang, Che Chen, Hong-Yan Wu. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta-analysis. Asian Pacific Journal of Cancer Prevention 2016; 16(18) doi: 10.7314/APJCP.2015.16.18.8653
|
| 7 |
Rémi Cousin, Hugo Groult, Chanez Manseur, Romain Ferru-Clément, Mario Gani, Rachel Havret, Claire Toucheteau, Grégoire Prunier, Béatrice Colin, Franck Morel, Jean-Marie Piot, Isabelle Lanneluc, Kévin Baranger, Thierry Maugard, Ingrid Fruitier-Arnaudin. A Marine λ-Oligocarrageenan Inhibits Migratory and Invasive Ability of MDA-MB-231 Human Breast Cancer Cells through Actions on Heparanase Metabolism and MMP-14/MMP-2 Axis. Marine Drugs 2021; 19(10) doi: 10.3390/md19100546
|
| 8 |
Lei Yan, Keqiang Yan, Wang Kun, Lin Xu, Qian Ma, Yueqing Tang, Wei Jiao, Gangli Gu, Yidon Fan, Zhonghua Xu. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase. Tumor Biology 2013; 34(1) doi: 10.1007/s13277-012-0531-z
|
| 9 |
Dyar Mudhafar Salman, Talar Ahmad Merza Mohammad. siRNA-based therapy for gastric adenocarcinoma: what’s next step?. Pathology - Research and Practice 2024; 258 doi: 10.1016/j.prp.2024.155328
|
| 10 |
Soo-Ling Lo, Aye Aye Thike, Soo-Yong Tan, Tony Kiat-Hon Lim, Iain Bee-Huat Tan, Su-Pin Choo, Puay-Hoon Tan, Boon-Huat Bay, George Wai-Cheong Yip. Expression of heparan sulfate in gastric carcinoma and its correlation with clinicopathological features and patient survival. Journal of Clinical Pathology 2011; 64(2) doi: 10.1136/jcp.2010.087478
|
| 11 |
Hao Jin, Min Cui. Gene silencing of heparanase results in suppression of invasion and migration of gallbladder carcinoma cells. Bioscience, Biotechnology, and Biochemistry 2018; 82(7) doi: 10.1080/09168451.2018.1456316
|